Clinical trials: Myelosuppression

Chemotherapy-induced Myelosuppression

Careseng 1370 for Healthy Volunteers

• Terminated
• Age: 20 to 40 years
• Phase 1
• Results posted

This study will be performed in healthy volunteers in a conventional 3+3 dose-escalation design.

Trial name

NCT03974516

Testing

Careseng 1370

Where

Taiwan

Volunteers

13 people, healthy volunteers welcome

Sponsor

i Cure Biotech Co., Ltd.